1-对甲苯磺酰基-3-吡咯烷醇 | 170456-83-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-对甲苯磺酰基-3-吡咯烷醇
• 英文名称: 1-tosylpyrrolidin-3-ol
• 英文别名: 1-tosyl-3-(R)-(-)-hydroxypyrrolidine；1-Tosyl-3-pyrrolidinol；1-(4-methylphenyl)sulfonylpyrrolidin-3-ol
• CAS: 170456-83-4
• 化学式: C₁₁H₁₅NO₃S
• mdl: MFCD16251506
• 分子量: 241.311
• InChiKey: GOIRRXGVYYWCGC-UHFFFAOYSA-N

物化性质

• 熔点：
  88-100 °C
• 沸点：
  406.8±55.0 °C(Predicted)
• 密度：
  1.338±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于二氯甲烷、乙酸乙酯、甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  66
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-对甲苯磺酰基-3-吡咯烷醇 在 溴 、 溶剂黄146 、 pyridinium chlorochromate 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.08h， 生成 2-methyl-5-(toluene-4-sulfonyl)-4,5,6,6a-tetrahydropyrrolo<4,3-d>thiazol-3a-ol
  参考文献：
  名称：

  Synthesis and Antibacterial Activity of 1-Cyclopropyl-6,8-difluoro-7-(2-substituted 4,6-dihydro-1H-pyrrolo[3,4-d]thiazol-5-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid

  摘要：

  Quinolone derivatives (9 and 10) substituted with bicyclothiazole (7) and (8) at C-7 position were synthesized. Bicyclothiazole derivatives (7 and 8) were prepared through 9 steps by way of the 4-bromo-3-oxopyrrolidine (16) was a key intermediate and introduced into the title compounds as new C-7 substituents. In vitro antibacterial activity of 9 and 10 was also reported.

  DOI：

  10.3987/com-94-6916
• 作为产物：
  描述：

  (+/-)-N-p-toluenesulfonyl-3-tert-butyldiphenylsilylmethyl pyrrolidine 在 potassium hydride 、 丁酸 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 24.0h， 以75%的产率得到1-对甲苯磺酰基-3-吡咯烷醇
  参考文献：
  名称：

  A smooth rearrangement of N-p-toluenesulfonyl 2-tert-butyldiphenylsilylmethyl-substituted azetidines into N-p-toluenesulfonyl 3-tert-butyldiphenylsilyl-substituted pyrrolidines

  摘要：

  在二氯甲烷的刘易斯酸条件下，N-对甲苯磺酰基2-叔丁基二苯基硅甲基取代的氮杂环丁烷被重新排列为3-叔丁基二苯基硅基取代的吡咯烷，其中硅通过硅化铵离子发生1,2-迁移。通过对3-和4-取代-2-叔丁基二苯基硅甲基氮杂环丁烷形成的吡咯烷产物进行立体化学分析，以及通过对N-对甲苯磺酰基2(R)-叔丁基二苯基硅甲基氮杂环丁烷形成的吡咯烷产物进行旋光数据和手性高效液相色谱分析，发现硅化铵离子的形成与σC-N断裂并不一致。空间位阻较小的硅化铵离子形成后，内部氮亲核试剂会对其进行SN2开环。σC-Si键的氧化断裂会导致3-羟基吡咯烷的形成。

  DOI：

  10.1039/c2ob07140a

文献信息

• Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150231142A1

  公开（公告）日：2015-08-20

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
  申请人：Van Goor Fredrick F.

  公开号：US20110098311A1

  公开（公告）日：2011-04-28

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• Copper-Catalyzed Reductive Trifluoromethylation of Alkyl Iodides with Togni’s Reagent
  作者：Yanchi Chen、Guobin Ma、Hegui Gong

  DOI：10.1021/acs.orglett.8b02005

  日期：2018.8.3

  This work illustrates a reductive cross-electrophile coupling protocol for trifluoromethylation of alkyl iodides under Cu-catalyzed/Ni-promoted reaction conditions. The use of diboron esters as the terminal reductant allows the effective generation of the alkyl–CF3 products with excellent functional group tolerance and broad substrate scope. A mechanism involving a reaction of alkyl–Cu with Togni’s

  这项工作说明了在Cu催化/ Ni促进的反应条件下烷基碘的三氟甲基化的还原性交亲电子偶联方案。使用二硼酸酯作为末端还原剂可以有效生成具有出色的官能团耐受性和广泛的底物范围的烷基-CF 3产物。提出了一种涉及烷基铜与Togni试剂反应的机理。
• Nickel-Catalyzed Sonogashira Reactions of Non-activated Secondary Alkyl Bromides and Iodides
  作者：Jun Yi、Xi Lu、Yan-Yan Sun、Bin Xiao、Lei Liu

  DOI：10.1002/anie.201307069

  日期：2013.11.18

  A nicked reaction: The title reaction of terminal alkynes with non‐activated secondary alkyl iodides and bromides was accomplished for the first time. This reaction provides a new and practical approach for the synthesis of substituted alkynes (see scheme; cod=cyclo‐1,5‐octadiene).

  昵称反应：首次完成末端炔与未活化的仲烷基碘和溴化物的标题反应。该反应为合成取代炔烃提供了一种新的实用方法（见方案； cod = cyclo-1,5-辛二烯）。
• Copper-Catalyzed Cross-Coupling between Alkyl (Pseudo)halides and Bicyclopentyl Grignard Reagents
  作者：Claire Andersen、Vincent Ferey、Marc Daumas、Patrick Bernardelli、Amandine Guérinot、Janine Cossy

  DOI：10.1021/acs.orglett.0c02115

  日期：2020.8.7

  The development of a copper-catalyzed cross-coupling between primary and secondary (pseudo)halides and bicyclopentyl Grignard reagents is reported. Highly strained bicyclopentanes can be cross-coupled with a large panel of primary alkyl mesylates and secondary alkyl iodides. The catalytic system is simple and cheap, and the reaction is general and chemoselective.

  据报道，伯和仲（伪）卤化物与双环戊基格氏试剂之间存在铜催化的交叉偶联。高度应变的双环戊烷可与一大批伯烷基甲磺酸酯和仲烷基碘化物交联。该催化体系简单且便宜，并且反应是一般的和化学选择性的。